MadeAi™, developed by CapeStart, is a GenAI platform that streamlines life sciences evidence synthesis workflows. Its flagship solution, MadeAi-LR, accelerates literature reviews by up to 60% while maintaining over 90% accuracy. MadeAi enables additional evidence synthesis workflows including GVDs, MIRs, CERs, and JCA assistance, among others. The platform combines advanced machine learning with human validation to ensure FDA and EMA compliance. MadeAi is headquartered in Cambridge, Massachusetts and supported by CapeStart’s global team of 600+ professionals.

MadeAi

1 Broadway serves as a key hub for sales leadership and strategy within the organization, driving revenue growth.

People (1)

Jobs (0)

Other offices